Yusa Sei-Ichi, Campbell Kerry S
Division of Basic Science, Fox Chase Cancer Center, Institute for Cancer Research, Philadelphia, PA 19111, USA.
J Immunol. 2003 May 1;170(9):4539-47. doi: 10.4049/jimmunol.170.9.4539.
The inhibitory forms of killer cell Ig-like receptors (KIR) are MHC class I-binding receptors that are expressed by human NK cells and prevent their attack of normal cells. Substantial evidence indicates that the mechanism of KIR-mediated inhibition involves recruitment of the protein tyrosine phosphatase, Src homology region 2-containing protein tyrosine phosphatase (SHP)-1, to phosphorylated immunoreceptor tyrosine-based inhibitory motifs (ITIMs). However, the functional significance of parallel recruitment of a SHP-1-related phosphatase, SHP-2, to KIR ITIMs has not been addressed. In the present study, our results with mutant forms of a classical KIR, KIR3DL1, show a direct correlation between SHP-2 recruitment and functional inhibition of target cell conjugation and cytotoxicity. In addition, KIR3DL1 inhibition of target cell cytotoxicity is blocked by overexpression of a dominant-negative form of SHP-2. Finally, KIR3DL1 fused directly with the catalytic domain of SHP-2 inhibits both target cell conjugation and cytotoxicity responses. These results strongly indicate that SHP-2 catalytic activity plays a direct role in inhibitory KIR functions, and SHP-2 inhibits NK cell activation in concert with SHP-1.
杀伤细胞免疫球蛋白样受体(KIR)的抑制性形式是与MHC I类结合的受体,由人类自然杀伤(NK)细胞表达,可防止其攻击正常细胞。大量证据表明,KIR介导的抑制机制涉及将蛋白酪氨酸磷酸酶——含Src同源区2的蛋白酪氨酸磷酸酶(SHP)-1招募至磷酸化的基于免疫受体酪氨酸的抑制性基序(ITIM)。然而,将与SHP-1相关的磷酸酶SHP-2平行招募至KIR ITIM的功能意义尚未得到探讨。在本研究中,我们对经典KIR——KIR3DL1的突变形式进行研究,结果显示SHP-2的招募与靶细胞结合及细胞毒性的功能抑制之间存在直接关联。此外,SHP-2的显性负性形式的过表达可阻断KIR3DL1对靶细胞细胞毒性的抑制作用。最后,直接与SHP-2催化结构域融合的KIR3DL1可抑制靶细胞结合及细胞毒性反应。这些结果有力地表明,SHP-2催化活性在KIR抑制性功能中起直接作用,且SHP-2与SHP-1协同抑制NK细胞活化。